Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options

Creative Commons License

ÇETİN G., EŞKAZAN A. E., AR M. C., Aydin S. O., Ferhanoglu B., Soysal T., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.31, no.4, pp.374-380, 2014 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.4274/tjh.2013.0004
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.374-380
  • Keywords: Multiple myeloma, Bone-specific alkaline phosphatase, Bortezomib, Thalidomide, BIOCHEMICAL MARKERS, KAPPA-B, BORTEZOMIB, DEXAMETHASONE, DISEASE, GROWTH, COMBINATION, THALIDOMIDE, PREDNISONE, METABOLISM
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objective: This study aimed to investigate the impact of the different therapy regimens used in multiple myeloma (MM) on bone-specific alkaline phosphatase (BALP) levels.